We develop the
drug candidate BAFA



Miguel Forte
Project manager Miguel Forte

Miguel is  MD and PhD.

Miguel is a pharmaceutical Industry executive with more than 20 years of experience in leading operational and strategic functions at all stages clinical development from early stages of academia, via industry first-in-man translation to launch and commercialization. Experience in large organizations as well as in start-up environment.

Other assignments

Board Member Essenscia Waterloo and Invited Associate Professor Faculdade de Farmácia da Universidade de Lisboa.

Lars Fändriks
Medical Research & Science: Lars Fändriks, Founder

Lars is a Medical Doctor and PhD. Professor at the Dept of Surgery, Sahlgrenska Academy, University of Gothenburg.

Lars has studied the functions of surgical techniques for over 30 years and has during the last 15 years been focused on weight-reducing surgery. He is together with Associate Professor Ville Wallenius the inventor behind Epicyt Pharma AB.

Other assignments

Founder and former board member of several companies, eg. Vicore Pharma AB and Epicyt Pharma AB. He is CEO in BENF AB.

Holds 256 000 shares in Epicyt Pharma AB through BENF AB.

Anders Rabbe
External expert in Biotech: Anders Rabbe

Anders holds a Bachelor of Economics in business administration from Webster University, Genève.

Anders has been the CEO of several companies within the biotech and the financial sector. For 10 years, Anders held the position as CEO of Isofol Medical AB (publ), developing the cancer drug candidate arfolitixorin.

Other assignments

Anders is CEO of Mindforce Game Lab. Board member of Baricol Bariatrics AB, Investmentaktiebolaget Akkumula AB and Albonja AB.

Holds 162 148 shares in Epicyt Pharma AB through Albonja AB.